(Q38866692)

7 September 2017

In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens (English)

1 reference

7 September 2017

0 references

Maged Al-Sherbiny

1

1 reference

7 September 2017

Ahmed Osman

2

1 reference

7 September 2017

Rashida Barakat

3

1 reference

7 September 2017

Hala El Morshedy

4

1 reference

7 September 2017

Robert Bergquist

5

1 reference

7 September 2017

Richard Olds

6

1 reference

7 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14516923

15 March 2024

publication date

1 October 2003

1 reference

full work available at URL

7 September 2017

https://api.elsevier.com/content/article/PII:S0001706X03001955?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0001-706X(03)00195-5

https://api.elsevier.com/content/article/PII:S0001706X03001955?httpAccept=text/plain

15 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0001-706X(03)00195-5

15 March 2024

1 reference

7 September 2017

88

1 reference

7 September 2017

117-130

1 reference

7 September 2017

2

1 reference

Functional diversity of helper T lymphocytes

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines: I. Assessment of 'resistance' versus 'susceptibility' to S. japonicum infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Schistosomiasis vaccine development: progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Schistosomiasis vaccine:research to development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Immunity to schistosomes: progress toward vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Development of a vaccine strategy against human and bovine schistosomiasis. Background and update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Vaccine strategies against schistosomiasis: from concepts to clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

A comparative analysis of the cost-effectiveness of treatment based on parasitological and symptomatic screening for Schistosoma mansoni in Burundi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Immunopathology of schistosomiasis mansoni in mice and men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

The global status of schistosomiasis and its control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Schistosoma and related genera: Acquired resistance in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Puberty and Age-related Changes in Susceptibility to Schistosome Infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. VI. Antigen recognition by non-responder mouse strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Helper T cell subsets: heterogeneity, functions and development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

The B cell epitope of paramyosin recognized by a protective monoclonal IgE antibody to Schistosoma japonicum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

The development of schistosomiasis mansoni in an immunologically naive immigrant population in Masongaleni, Kenya.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Dilemmas in drug development for tropical diseases. Experiences with praziquantel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Human immune responses to Schistosoma mansoni vaccine candidate antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Schistosoma mansoni: induction of protective immunity in rats using a recombinant fragment of a parasite surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Resistance to reinfection after treatment of urinary schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

Immunity and morbidity in Schistosoma mansoni infection: quantitative aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Candidate vaccine antigens identified by antibodies from mice vaccinated with 15- or 50-kilorad-irradiated cercariae of Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900195-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Multicentre trials of praziquantel in human schistosomiasis: design and techniques

20

1 reference

https://api.crossref.org/works/10.1016/S0001-706X(03)00195-5

15 March 2024

Identifiers

1 reference

7 September 2017

1 reference